Dr. Michael Demeure, MD
Claim this profileHoag Memorial Hospital Presbyterian
Studies Pancreatic Cancer
Studies Tumors
7 reported clinical trials
6 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
2Tumors
Stage IV
Stage III
TP53 negative
Affiliated Hospitals
Clinical Trials Michael Demeure, MD is currently running
Nab-Sirolimus
for Neuroendocrine Tumors
This trial tests nab-sirolimus, a drug that targets tumors, in patients with advanced neuroendocrine tumors of the GI tract, lung, or pancreas. The drug works by blocking a protein that helps tumor cells grow and survive. Nab-sirolimus is the first agent specifically approved for advanced unresectable or metastatic malignant PEComa.
Recruiting1 award Phase 212 criteria
Selpercatinib
for Solid Tumors
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Recruiting1 award Phase 1 & 215 criteria
More about Michael Demeure, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Demeure, MD has experience with
- Nab-sirolimus
- Ulixertinib (BVD-523)
- Observational Study
- ASTX295
- Multi-Cancer Early Detection Test
- LOXO-292
Breakdown of trials Michael Demeure, MD has run
Pancreatic Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Demeure, MD specialize in?
Michael Demeure, MD focuses on Pancreatic Cancer and Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Michael Demeure, MD currently recruiting for clinical trials?
Yes, Michael Demeure, MD is currently recruiting for 2 clinical trials in Newport Beach California. If you're interested in participating, you should apply.
Are there any treatments that Michael Demeure, MD has studied deeply?
Yes, Michael Demeure, MD has studied treatments such as nab-sirolimus, Ulixertinib (BVD-523), Observational Study.
What is the best way to schedule an appointment with Michael Demeure, MD?
Apply for one of the trials that Michael Demeure, MD is conducting.
What is the office address of Michael Demeure, MD?
The office of Michael Demeure, MD is located at: Hoag Memorial Hospital Presbyterian, Newport Beach, California 92663 United States. This is the address for their practice at the Hoag Memorial Hospital Presbyterian.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.